Skip to main content

Table 2 HIV treatment data of adolescents aged 10–19 years old on ART and enrolled in the cross-sectional survey at Myittar Yeik Clinic, by sex, 2016

From: High levels of viral repression, malnutrition and second-line ART use in adolescents living with HIV: a mixed methods study from Myanmar

 

Total

Female

Male

P-value

# (%)

# (%)

# (%)

 

Age (years) at ART start

   

0.513

<=5

92 (52)

45 (47)

47 (58)

 

6–9

64 (36)

38 (40)

26 (32)

 

10–13

14 (7.9)

9 (9.4)

5 (6.2)

 

14–19

7 (4.0)

4 (4.2)

3 (3.7)

 

WHO status at cohort entry

   

0.007

1

41 (23)

13 (14)

28 (35)

 

2

52 (29)

32 (33)

20 (25)

 

3

72 (41)

43 (45)

29 (36)

 

4

11 (6.2)

8 (8.3)

3 (3.7)

 

Missing

1 (0.6)

0 (0.0)

1 (1.2)

 

CD4 count at cohort entry

   

0.625

< 200

34 (19)

22 (23)

12 (15)

 

200–350

14 (7.9)

6 (6.3)

8 (9.9)

 

351–500

12 (6.8)

7 (7.3)

5 (6.2)

 

> 500

65 (37)

33 (34)

32 (40)

 

Missing

52 (29)

28 (29)

24 (30)

 

Current ART regimen

   

0.090

First-line treatment

139 (79)

80 (83)

59 (73)

 

Second-line treatment

38 (21)

16 (17)

22 (27)

 

Mean time (years) on any ART regimen, SD

6.6 (2.7)

6.7 (2.7)

6.5 (2.4)

0.703

Mean time (years) on current ART regimen, SD

2.1 (1.0)

2.3 (1.0)

1.9 (0.8)

0.010

  1. Includes results up to 6 months after cohort entry